A pilot study of the clinical efficacy and safety of memantine for Huntington's disease

被引:72
作者
Ondo, William G. [1 ]
Mejia, Nicte I.
Hunter, Christine B.
机构
[1] Baylor Coll Med, Parkinsons Dis Ctr, Houston, TX 77030 USA
[2] Baylor Coll Med, Dept Neurol, Movement Disorders Clin, Houston, TX 77030 USA
关键词
D O I
10.1016/j.parkreldis.2006.08.005
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
引用
收藏
页码:453 / 454
页数:2
相关论文
共 5 条
[1]  
Beister A, 2004, J NEURAL TRANSM-SUPP, P117
[2]  
KORNHUBER J, 1994, J NEURAL TRANSM-SUPP, P91
[3]   Memantine inhibits and reverses the Alzheimer type abnormal hyperphosphorylation of tau and associated neurodegeneration [J].
Liang, L ;
Sengupta, A ;
Haque, N ;
Grundke-Iqbal, I ;
Iqbal, K .
FEBS LETTERS, 2004, 566 (1-3) :261-269
[4]  
Metman LV, 2002, NEUROLOGY, V59, P694
[5]   Distinct effects of amantadine and memantine on dopaminergic transmission in the rat striatum [J].
Peeters, M ;
Maloteaux, JM ;
Hermans, E .
NEUROSCIENCE LETTERS, 2003, 343 (03) :205-209